Annals of Chinese Medicine <p><strong>Annals of Chinese Medicine (ACM)</strong> is a newly established peer-reviewed journal open access journal. <strong>Annals of Chinese Medicine</strong> is an interdisciplinary journal focusing on academic research and clinical studies in the field of Chinese Meidicne. It aims to be a leading journal for studies in this field and to promote blending of among acupuncture, herbal medicine, complementary and alternative medicine (CAM), and bio-medicine. The editorial board of <strong>Annals of Chinese Medicine</strong> is committed to publishing high-quality papers on acupuncture an open forum for various disciplines.</p> <p><strong>Annals of Chinese Medicine</strong> covers&nbsp; all aspects of Chinese Medicine, including acupuncture,&nbsp; moxibustion, herbal medicine and other forms of CAM approaches, e.g. mind-body medicine, diet, Taichi, Qigong, meditation, as well as their integration with the conventional medicine.</p> <p>Article types include, but are not limited to, reviews, meta-analyses, clinical trails, clinical protocols, &nbsp;basic science studies, papers on methodology and medical history or education, conference proceedings, and so on.</p> <p><strong>The first issus is scheduled to be published on Mar. 01, 2020 and it's free to publish with Annals of Chinese Medicine before Mar.01,2020.</strong></p> Heyttu en-US Annals of Chinese Medicine 2596-8653 <p>Authors and <strong><em>Annals of Chinese Medicine</em></strong>&nbsp;co-hold the copyright of their manuscripts, and all Open Access articles&nbsp; are distributed under the terms of the&nbsp;<a href="">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. Once a manuscript is allowed by the author to published with the journal, The Acupuncturist holds the copyright and permission from the authors to reuse, print and commercially distribute the published articles, provided that the original work is properly cited.&nbsp;</p> <p>The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. The submitting author is responsible for securing any permissions needed for the reuse of copyrighted materials included in the manuscript.</p> <p>While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.</p> Treatment for Multiple Sclerosis:Kidney-Du-Brain Axis (KIDUBA) Acupuncture Protocol <p>Multiple sclerosis (MS) is a complex autoimmune disease mediated by an immune response to central nervous system antigens. Conventional immunomodulatory therapies are limited to relieve&nbsp;many of the symptoms, such as weakness, pain and depression, but probably cause side effects. Acupuncture, the most popular approach of complementary and alternative medicine (CAM) could improve the quality of life (QoL), fatigue, and pain, and alleviate the side-events of immunosuppresants. The essay summarized the publications&nbsp;and experiences from the leading acupuncture masters in China and clinical trails on acupuncture treatment for MS patients. The review concluded that in Chinese Medicine (CM), the Kidney-DU-Brain Axis (KIDUBA) plays a key role in the pathogenesis of MS. Fundamental acupoints including GB39, SP6, DU4, BL23, SI3, Sishencong are recommended according to the principle of supplementing kidney and marrow and opening blockages&nbsp;in&nbsp;Du channel and the brain. Besides, acupuncture treatment for the side effects of immunomodulatory medications are covered in the protocol.</p> Hui Zhang Han Lai Copyright (c) 2019 Annals of Acupuncture 2019-05-17 2019-05-17 1 1 9 9